 |
| Nippon India Pharma Fund - Direct (IDCW) |
|
|
|
|
|
|
| Summary Info |
|
| Fund Name : |
Nippon India Mutual Fund |
| Scheme Name : |
Nippon India Pharma Fund - Direct (IDCW) |
| AMC : |
Nippon India Mutual Fund |
| Type : |
Open |
| Category : |
Equity - Pharma |
| Launch Date : |
01-Jan-13 |
| Fund Manager : |
Sailesh Raj Bhan |
| Net Assets:(Rs in Cr) |
8080.97 |
|
|
| NAV Graph |
|
|
|
|
|
|
| NAV Details |
|
| NAV Date : |
29-Apr-25 |
| NAV [Rs] : |
163.00 |
| Buy/Repurchase [Rs] : |
0.00 |
| Sell/Resale [Rs] : |
0.00 |
| Entry Load % : |
NIL |
| Exit Load % : |
1% if redeemed or switchd out on or before completion of 1 Months from the date of allotment of units. NIl if redeemed or switched out after the completion of 1 Months from the date of allotment of units. |
|
|
|
| Latest Payouts |
|
| |
Dividends |
Bonus |
|
| Ratio |
100 % |
NA |
| Date |
23-Feb-24 |
NA |
|
|
|
|
| Investment Details |
|
| Tax Benefits : |
NA |
| Min. Investment(Rs) : |
5000 |
| Increm.Investment(Rs) : |
1000 |
|
|
|
|
|
|
| |
1 Week |
1 Month |
3 Month |
6 Month |
1 Year |
3 Year |
5 Year |
Since INC |
|
|
|
|
|
|
|
| Statistical Ratios |
What
is Beta ?
Beta is a measure of the volatility of the portfolio to that of the index. In
simple words it shows the movement of the portfolio in comparison. The Higher
the Beta, higher the volatility of the scheme to the index. If its greater
than1 , then the portfolio is highly volatile to the movements in the index. If
the beta is lesser than 1 , then scheme is less volatile to the index and beta
which is close to 1 implies that the scheme is closely following the index.
|
|
| Beta [%] |
SD [%] |
Sharpe Ratio [%] |
Jensons Alpha [%] |
TR [%] |
|
| 0.7741 |
4.5758 |
0.8193 |
9.8746 |
0.0683 |
|
|
|
|
| Asset Allocation |
|
|
|
|
|
|
|
| Holdings |
31-Mar-25 |
|
| Company Name |
% Hold |
|
| Sun Pharma.Inds. |
13.43 |
| Divi's Lab. |
9.28 |
| Lupin |
7.27 |
| Cipla |
5.71 |
| Apollo Hospitals |
5.31 |
| Dr Reddy's Labs |
5.19 |
| Glaxosmi. Pharma |
3.61 |
| Vijaya Diagnost. |
3.53 |
| Abbott India |
3.46 |
| Medplus Health |
3.41 |
| Ajanta Pharma |
3.11 |
| Gland Pharma |
3.01 |
| Narayana Hrudaya |
2.99 |
| Aurobindo Pharma |
2.45 |
| Zydus Lifesci. |
2.19 |
| Dr Lal Pathlabs |
2.18 |
| Torrent Pharma. |
2.01 |
| J B Chemicals & |
2.01 |
| Alkem Lab |
1.96 |
| Mankind Pharma |
1.95 |
| Sanofi India |
1.63 |
| Pfizer |
1.58 |
| Thyrocare Tech. |
1.49 |
| Ipca Labs. |
1.46 |
| Sai Life |
1.35 |
| Sanofi Consumer |
1.28 |
| Suraksha Diagno. |
1.02 |
| Syngene Intl. |
1.01 |
| Biocon |
0.97 |
| Fortis Health. |
0.95 |
| Astrazeneca Phar |
0.68 |
| Indoco Remedies |
0.53 |
| Orchid Pharma |
0.47 |
| Emcure Pharma |
0.40 |
| Krishna Institu. |
0.37 |
| Concord Biotech |
0.23 |
| TREPS |
0.70 |
| Net CA & Others |
-0.18 |
| C C I |
0.00 |
|
|
|
|
|